0.00%. On June 26, 2022, Brookline Capital Acquisition Corp., a Delaware corporation ("BCAC"), entered into Amendment No. Brookline Capital Acquisition Corp is a blank check company. Get the latest business insights from Dun & Bradstreet. Brookline Capital Acquisition Corp - Company Profile and News - Bloomberg Markets Company profile page for Brookline Capital Acquisition Corp including stock price, company news, press releases,. New York, NY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (NASDAQ: BCACU) (the "Company") announced today that, commencing February 22, 2021, holders of the 5,750,000 . Shareholder Meeting. It is formed for the purpose of effecting into a merger .

Conference Call Information. AUDIT COMMITTEE CHARTER . It is formed for the purpose of effecting into a merger . Brookline Capital Acquisition Corp. Common Stock (BCAC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization,. 3/31/2022 WOLVERINE ASSET MANAGEMENT LLC Bought 8.4 Thousand shares of Brookline Capital Acquisi. BROOKLINE CAPITAL ACQUISITION CORP. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq . The business has a 50 day moving average of $10.09 and a two-hundred day moving . It is formed for the purpose of effecting into a merger . Brookline Capital Acquisition Corp is primarely in the business of blank checks. Exhibit 99.1 . Company profile page for Brookline Capital Acquisition Corp including stock price, company news, press releases, executives, board members, and contact information

. . It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the life sciences industry. Confirms Receipt of Sponsor Funds to Extend Period of Time to Consummate Business Combination and for Additional Working Capital 4/25/2022 Apexigen to Host Investor Day to Provide an Overview of its Antibody Therapeutic Pipeline and Unique APXiMAB Platform on Monday, May 16, 2022 3/18/2022 It is formed for the purpose of effecting into a merger . Brookline Capital Acquisition Corp (Nasdaq: BCAC) Overview Brookline Capital Acquisition Corp ("BCAC") is a Nasdaq- Listed SPAC that completed a $57.5M IPO on January 29, 2021 BCAC is sponsored by Brookline Capital Markets, a division of Arcadia Securities LLC, a boutique healthcare investment bank 3 BCAC Competitive Advantages It is formed for the purpose of effecting into a merger . The Company may pursue an acquisition opportunity in any industry or sector, it intends . Continental Stock Transfer & Trust Company 1 State Street 30th Floor New York, NY 10004-1561 Domestic: 212-509-4000 International: +1-212-509-4000 www . It is formed for the purpose of effecting into a merger . I Shareholders Approve Extension from July 11, 2022 to August 11, 2022 and up to 5 additional one month extensions until January 11, 2023 . The Brookline Brief Contact - Brookline Capital Acquisition Corp Contact BCAC@brooklinecapmkts.com (646) 603-6716 600 Lexington Avenue Floor 33 New York, NY 10022 Loading. BROOKLINE CAPITAL ACQUISITION CORP. Brookline Capital Acquisition Corp Schedules Shareholder Meeting on July 27, 2022 to Vote for Business Combination with Apexigen - BCAC BCACW. It is formed for the purpose of effecting into a merger . The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Brookline Capital Acquisition Corp. BCACU.OQ. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Our greatest source of pride is the success and longevity of our clients as they grow and flourish. It intends to acquire companies in the life . Shares of BCAC stock opened at $10.11 on Tuesday. The past year's Return on Average Assets were at -0.0072. Official Data Partner. Brookline Capital Acquisition Corp. jest spk typu "blank check". The company was founded in 2020 and is based in . New York, NY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (NASDAQ: BCACU) (the "Company") announced today that, commencing February 22, 2021, holders of the 5,750,000 . Latest Trade. Brookline Capital Acquisition Corp. does not have significant operations. This certificate and the shares . Mountain Crest Acquisition III: 69.73M: First US Bancshares: 65.31M . Contact 280 Park Avenue, Suite 43W New York, NY, 10017 T +1 646 643-6716 www.brooklinecapitalacquisitioncorp.com Sector Financial. BCAC has a market cap or net worth of $68.54 million as of July 2, 2022, making it the 5,244th biggest public company in the US. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. Search: Miles Capital Acquisition. New York, NY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (NASDAQ: BCACU) (the "Company") announced today that, commencing February 22, 2021, holders of the 5,750,000. com is a great place to look for and post law firm job listings IIB 111th CONGRESS 1st Session H The US-based broker and clearing house first revealed its intention for the acquisition in late February after receiving approval from the board of both the companies (Nasdaq: SSNC), today introduced results from the Q1 2021 issue of Joe Tsai, Executive Vice . It is formed for the purpose of effecting into a merger . Brookline Capital Acquisition Corp. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Brookline Capital Acquisition Corp. (NASDAQ:BCAC - Get Rating. Upon closing of the transaction, Brookline Capital Acquisition Corp. will be renamed Apexigen, Inc. (the "Combined Company") and will be led by Xiaodong Yang, M.D., Ph.D., President and Chief. Brookline Capital Acquisition Corp. (the "Company") is a newly organized blank check company incorporated in Delaware and formed for the purpose of effecting a merger, share e Get the latest info and learn more about Brookline Capital Acquisition Corp.(BCAC) capital.com. | July 5, 2022 This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K . Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. It was formed for the purpose of entering into a merger . Brookline Capital Acquisition Corp. (Exact name of registrant as specified in its charter) _____ Delaware 6770 85-1260244 (State or other jurisdiction of .

Company Description. Brookline Capital. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. View the latest Brookline Capital Acquisition Corp. (BCAC) stock price, news, historical charts, analyst ratings and financial information from WSJ. Brookline is recognized for its differentiated ability to source capital from traditional institutional investors, as well as from its proprietary network of global family offices and high net worth investors. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Brookline Capital Acquisition Corp.. . Click here to vote your proxy online. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.37 Market Cap $68.54 M Shares Outstanding 6.75 M Public. WALLEYE CAPITAL LLC Bought 18.9 Thousand shares of Brookline Capital Acquisi. View today's Brookline Capital Acquisition Corp stock price and latest BCACU news and analysis. I Shareholders Approve Extension from July 11, 2022 to August 11, 2022 and up to 5 additional one month extensions until January 11, 2023 . BCAC's market cap has decreased by -6.88% in one year. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. View the BCAC U.S. Securities and Exchange Commission reporting information. BCAC's market cap has decreased by -6.88% in one year. Brookline Capital Acquisition stock opened at $10.17 on Wednesday. It intends to acquire companies in the life sciences sector. USD . The Company will furnish without charge to each stockholder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof of the Company and the qualifications, limitations, or restrictions of such preferences and/or rights. Find company research, competitor information, contact details & financial data for Brookline Capital Acquisition Corp. of New York, NY. Mountain Crest Acquisition III: 69.73M: First US Bancshares: 65.31M . Change 0 % Change. Shareholder Meeting. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. References to the "Company," "Brookline Capital Acquisition Corp.," "Brookline," "our," "us" or "we" refer to Brookline Capital Acquisition Corp.The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. The Company will furnish without charge to each unitholder who so requests, a statement of the powers, designations, preferences and relative, participating, optional or other special rights of each class of stock or series thereof of the Company and the qualifications, limitations, or restrictions of such preferences and/or rights. Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. I. Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company; 2022-05-17: Glazer Capital LLC: 278,732 Off-Balance Sheet Arrangement of a Registrant. . BROOKLINE CAPITAL ACQUISITION CORP. : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share BROOKLINE CAPITAL . A high-level overview of Brookline Capital Acquisition Corp. Units (BCACU) stock. sec.gov/Archiv. Find the latest Brookline Capital Acquisition Corp. (BCACW) stock quote, history, news and other vital information to help you with your stock trading and investing. Spka zostaa utworzona w celu przeprowadzenia fuzji, wymiany kapitaowej, przejcia aktyww, zakupu akcji, reorganizacji lub podobnego poczenia biznesowego z jednym lub wiksz liczb podmiotw. Get Brookline Capital Acquisition Corp. (BCAC:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Employer incorporation . Brookline Capital Acquisition Corp. is incorporated in the state of Delaware. Brookline Capital Return on Average Assets are projected to increase slightly based on the last few years of reporting. Vickers Vantage Corp. sec.gov/Archiv. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Purpose . The Audit Committee (the "Committee") of the Board of Directors (the "Board") of Brookline Capital Acquisition Corp., a Delaware corporation (the "Company"), shall provide assistance to the Board in fulfilling its legal and fiduciary obligations to oversee: For financial reporting, their fiscal year ends on December 31st. Capital Com Australia Limited Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) A high-level overview of Brookline Capital Acquisition Corp. Units (BCACU) stock. SAN CARLOS, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. ("Apexigen"), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer. Apexigen and Brookline Capital Acquisition Corp. will host a conference call today, Friday, March 18, 2022, at 8:30 a.m. Eastern Time, to discuss the proposed . Brookline Capital Acquisition Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of entering into a merger, share .